Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Psoriasis is a common, chronic, and inflammatory skin disease. Macrophages account for about 61.3% of the inflammatory cells infiltrating psoriatic lesions. Modulating macrophage polarization, inhibiting their infiltration, and targeting the secretion of inflammatory factors and associated inflammatory pathways by these cells can alleviate psoriasis symptoms and inflammation. Moreover, nanomaterials as novel drug carriers, offer unique advantages such as large surface area, easy modification, high biocompatibility, good biodegradability, enhanced systemic adsorption, etc. Nanomaterials have great potential for efficient drug delivery and release, as well as improving therapeutic efficacy while reducing adverse effects. By systematically addressing the role of macrophages in psoriasis pathogenesis and the potential of nanomaterials in treating psoriasis through modulating macrophages, this review enhances our understanding of the disease mechanism and holds promise for novel therapeutic breakthroughs and advancements in the future treatment of psoriasis.
Vol 30, No 2S2 (2016) - Article
Uncommon clinical presentation of Kimuras disease as bilateral retroauricular masses in a young Malian male: successful surgical approach Abstract
Vol 30, No 2S2 (2016) - Article
Medium-sized congenital melanocytic nevus of the forehead, glabella and temple surgical treatment and long-term follow-up Abstract
Vol 30, No 2S2 (2016) - Article
Multifocal infantile progressive hemangiomatosis with ocular involvement: unique presentation in a Bulgarian newborn Abstract
Vol 30, No 2S2 (2016) - Article
5-hydroxytryptamine and Lyme disease. Opportunity for a novel therapy to reduce the cerebellar tremor? Abstract
Vol 30, No 2S3 (2016) - Article
A European prospective, randomized placebo-controlled doubleblind Study on the efficacy and safety of Dr Michaels® (also branded as Soratinex®) product family for stable chronic plaque psoriasis Abstract
Vol 30, No 2S3 (2016) - Article
An innovative, promising topical treatment for psoriasis: a Romanian clinical study Abstract
Vol 30, No 2S3 (2016) - Article
Efficacy and safety of Dr Michaels® (Soratinex®) product family for the topical treatment of psoriasis: a monitored status study Abstract
Vol 30, No 2S3 (2016) - Article
Quality of life aspects of patients with psoriasis using a series of herbal products Abstract
Vol 30, No 2S3 (2016) - Article
Rapid communication: a vegetable oil extract restores redox status in fibroblasts from psoriatic patients Abstract
Vol 30, No 2S3 (2016) - Article
A clinical examination of the efficacy of preparation of Dr Michaels® (also branded as Soratinex®) products in the treatment of psoriasis Abstract
Vol 30, No 2S3 (2016) - Article
Nail psoriasis in an adult successfully treated with a series of herbal skin care products family – a case report Abstract
Vol 30, No 2S3 (2016) - Article
Clinical evaluation of the effectiveness of Dr Michaels®(also branded as Soratinex®) products in the topical treatment of patients with plaque psoriasis Abstract
Vol 30, No 2S3 (2016) - Article
Successful treatment of a chronic eczema in a 48-year-old female with Dr Michaels® (Eczitinex® and Itchinex®) product family. A case report Abstract
Vol 30, No 2S3 (2016) - Article
Dr Michaels® (Soratinex®) product for the topical treatment of psoriasis: a Hungarian/Czech and Slovak study Abstract
Vol 30, No 2S3 (2016) - Article
Successful treatment of mild to moderate acne vulgaris with Dr Michaels® (also branded as Zitinex®) topical products family: a clinical trial Abstract
Vol 30, No 2S3 (2016) - Article
Investigation of the efficacy and tolerability of Dr Michaels® (also branded as Eczitinex® and Itchinex Eczitinex®) topical products in the treatment of atopic dermatitis in children Abstract
Vol 30, No 2S3 (2016) - Article
Treatment of ichthyosis lamellaris using a series of herbal skin care products family Abstract
Vol 30, No 2S3 (2016) - Article
Investigation of the efficacy of Dr Michaels® (Soratinex®) family in maintaining a symptom-free state for patients with psoriasis in remission. A retrospective, comparative study Abstract
Vol 30, No 2S3 (2016) - Article
Dr Michaels® product family (also branded as Soratinex®) versus Methylprednisolone aceponate - a comparative study of the effectiveness for the treatment of plaque psoriasis Abstract
Vol 30, No 2S3 (2016) - Article
Successful treatment of alopecia areata with Dr. Michaels® (Alopinex) product family Abstract
Vol 30, No 2S3 (2016) - Article
Successful treatment of recalcitrant candidal intertrigo with Dr Michaels® (Fungatinex®) product family Abstract
Vol 30, No 2S3 (2016) - Article
A European prospective, randomized placebo-controlled doubleblind Study on the efficacy and safety of Dr Michaels® (also branded as Soratinex®) product family for stable chronic plaque psoriasis Abstract
Vol 30, No 2S3 (2016) - Article
Successful treatment of facial systemic lupus erythematosus lesions with Dr Michaels® (Soratinex®) product family. A case report Abstract
In addition to the first issue that has already been published by the original publisher, there will be four more issues released this year, with scheduled publication dates in March, June, September, and December respectively.
Starting from Volume 39 Issue 2 (2025), the ownership of Journal of Biological Regulators and Homeostatic Agents (ISSN: 0393-974X (P); 1724-6083 (O)) will be transferred from Biolife Sas to Asia Pacific Academy of Science Pte. Ltd. As of 21 January 2025, authors should make submissions to the new journal system and follow the author guidelines. Asia Pacific Academy of Science Pte. Ltd. will take over the publication of manuscripts being processed.
